发明名称 (17)-Alkynyl-(17)-hydroxy-(4,15)-oestradienones and derivs. - progestational agents inhibiting ovulation and implantation
摘要 <p>Steroids of formula (I) are new: (R1 = H, trialkylsilyl or acyl. R2 = ethynyl, chloroethynyl or propynyl. X is oxo, or NOR4. R3 = H or acyl. R4 = H, acyl, alkyl or tetrahydropyranyl). They are prepd. e.g. from corresp. 3-oxo cpds. by reaction with an organometallic cpd. able to introduce R2 giving a tert. carbinol. (I) have powerful progestational activity and inhibit ovulation and implantation; the higher esters have delayed-release activity. The oral doses contain 0.01-0.5 mg and parenteral solns. about 100 mg/ml. In the Clauberg test 17 alpha-ethynyl-17 beta-hydroxy-18-methyl-4,15-oestradien-3-one is more active orally than the corresp. -4-oestren-3-one.</p>
申请公布号 DE2636407(A1) 申请公布日期 1978.02.16
申请号 DE19762636407 申请日期 1976.08.12
申请人 SCHERING AG 发明人 HOFMEISTER,HELMUT,DR.;WIECHERT,RUDOLF,PROF.DR.;ANNEN,KLAUS,DR.;LAURENT,HENRY,DR.;STEINBECK,HERMANN,DR.
分类号 C07J1/00;C07J41/00;(IPC1-7):C07J1/00;A61K31/565 主分类号 C07J1/00
代理机构 代理人
主权项
地址